SINOPEC SHANGHAI-SPONS ADR (SHI)       15.74  +0.24 (+1.55%)

15.74  +0.24 (+1.55%)

US82935M1099 - ADR


Fundamental Rating

Taking everything into account, SHI scores 4 out of 10 in our fundamental rating. SHI was compared to 119 industry peers in the Chemicals industry. The financial health of SHI is medium. Also its profitability is quite bad. A decent growth rate in combination with a cheap valuation! Better keep an eye on SHI.




Profitability

Profitability Rating


SHI's Return On Assets of 1.94% is worse than the rest of the industry. The industry average Return On Assets is 4.56%.
SHI has a Return On Equity of 3.39%. This is below the industry average of 19.82%. 97% of the industry peers outperform SHI.

SHI has a Profit Margin of 1.10%. This is below the industry average of 6.71%.
SHI has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of SHI.
VS Industry

ROA (1.94%) VS Industry: 36% outperformed.

-270.86
34.90

ROE (3.39%) VS Industry: 3% outperformed.

1.71
192.48

Profit Margin (1.1%) VS Industry: 27% outperformed.

-93,795.35
86.52

Valuation

Valuation Rating


With a Price/Earnings Ratio of 10.93, the valuation of SHI can be described as very reasonable.
With a Forward Price/Earnings Ratio of 4.71, the valuation of SHI can be described as cheap.
When comparing the current price to the book value of SHI, it is valued rather cheaply. It is trading at 0.37 times its book value.

Compared to an average industry price book ratio of 2.34, SHI is valued rather cheaply. On top of this, SHI is cheaper than 95% of the companies listed in the same industry.
SHI's Price/Earning Ratio is in line with the industry average which is at 11.77.
SHI's PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VS Industry

Price/Earnings (10.93) VS Industry: 54% outperformed.

71.75
1.78

Price/Book (0.37) VS Industry: 95% outperformed.

994.49
0.08

Growth

Growth Rating


When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
SHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.00%.
SHI is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 9.65% yearly.
Measured over the past 5 years, SHI shows a small growth in Revenue. The Revenue has been growing by 2.77% on average per year.

SHI is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 0.58% yearly.
The earnings per share for SHI have decreased strongly by -64.86% in the last year.
SHI shows a very negative growth in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -19.63% yearly.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-19.63% -4.92% -64.86% 7.41% 10.38% 9.45% 9.65%
Revenue2.77% -6.08% 23% 9.84% 3.29% 2.23% 0.58%

Health

Health Rating


With a Debt to Equity ratio of 0.02, SHI is doing better than the averages in the industry. The industry average is at 0.53.
SHI has a Current Ratio of 1.17. This is a normal value and indicates that SHI is financially healthy and should not expect problems in meeting its short term obligations.
An Altman-Z score of 2.68 indicates that SHI is not a great score, but indicates only limited risk for bankruptcy at the moment.
SHI has a Altman-Z score comparable to the industry average, which is at 2.97.

When comparing the Current Ratio of SHI to the average industry Current Ratio of 2.11, SHI is less able to pay its short term obligations than its industry peers. 85% of its industry peers have a better Current Ratio.
A Quick Ratio of 0.74 indicates that SHI may have some problems paying its short term obligations.
When comparing the Quick Ratio of SHI to the average industry Current Ratio of 1.35, SHI is less able to pay its short term obligations than its industry peers. 85% of its industry peers have a better Quick Ratio.
SHI has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of SHI.
VS Industry

Debt/Equity (0.02) VS Industry: 80% outperformed.

7.55
0.00

Quick Ratio (0.74) VS Industry: 15% outperformed.

0.00
60.50

Current Ratio (1.17) VS Industry: 15% outperformed.

0.00
60.50

Altman-Z (2.68) VS Industry: 43% outperformed.

-251.35
156.96

Dividend

Dividend Rating


Compared to an average industry Dividend Yield of 2.31, SHI pays a bit more dividend than its industry peers.
SHI's Dividend Yield is a higher than the S&P500 average which is at 2.39.
SHI has paid a dividend for at least 10 years, which is a reliable track record.

With a Yearly Dividend Yield of 3.12%, SHI has a reasonable but not impressive dividend return.
The dividend of SHI decreases each year by -26.32%.
SHI pays out 112.76% of its income as dividend. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (3.12%) VS Industry: 65% outperformed.

0.31
19.73
SHI Daily chart

SINOPEC SHANGHAI-SPONS ADR15.74

NYSE:SHI (8/16/2022, 6:00:00 PM)+0.24 (+1.55%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Chemicals
Earnings (Last) 04-27 2022-04-27/dmh Earnings (Next) 08-26 2022-08-26
Ins Owners N/A Inst Owners 0.64%
Market Cap 1.70B Analysts 67.5
Valuation
PE 10.93 Fwd PE 4.71
PEG (NY) 1.47 PEG (5Y) N/A
P/S 0.12 P/B 0.37
EV/EBITDA N/A
Profitability
ROA 1.94% ROE 3.39%
PM 1.1 Asset Turnover 1.77
Growth
EPS 1Y -64.86% EPS 3Y -4.92%
EPS 5Y -19.63% EPS growth Q2Q -81.48%
EPS Next Y 7.41% EPS Next 2Y 10.38%
EPS Next 3Y 9.45% EPS Next 5Y 9.65%
Revenue growth 1Y 23% Revenue growth 3Y -6.08%
Revenue growth 5Y 2.77% Revenue growth Q2Q 27.61%
Revenue Next Year 9.84% Revenue Next 2Y 3.29%
Revenue Next 3Y 2.23% Revenue Next 5Y 0.58%
Health
Current Ratio 1.17 Quick Ratio 0.74
Altman-Z 2.68 F-Score 3
Debt/Equity 0.02
Dividend
Dividend Yield 3.12% Dividend Growth -26.32%
DP 112.76% Ex-Date 06-27 2022-06-27 (1.486662)

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA